Research and Development

Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company, announced that the first subjects have been enrolled in the MIRA-3 Phase III …

The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …

HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …

NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults who …

UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight …

Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in …

The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …

Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …

COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …

Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …

A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …